CAR-TCR

Hanson Wade is a pioneering organization dedicated to advancing the field of cell therapy through innovative conferences and summits. Notably, the brand hosts the CAR-TCR Summit Europe, a premier event that brings together over 300 experts and opinion leaders from the immunotherapy landscape to explore groundbreaking advances in CAR-TCR technology. The summit features in-depth discussions on safety, efficacy, and manufacturing processes, providing a platform for industry leaders to connect and share insights on next-generation therapies.

Hanson Wade focuses on various aspects of drug development, including discovery and clinical development, by facilitating connections among researchers, scientists, and executives. Their events feature multiple tracks that cater to diverse segments of the cell therapy sector, from translational research to process development. By uniting thought leaders and fostering collaboration, Hanson Wade plays a critical role in shaping the future of personalized and targeted therapies, ultimately contributing to the improvement of patient outcomes across the globe.